Evaluation of the expression of cytokines and chemokines in macrophages in response to rifampin-monoresistant Mycobacterium tuberculosis and H37Rv strain

被引:4
作者
Ravan, Parvaneh [1 ]
Sattari, Taher Nejad [1 ]
Siadat, Seyed Davar [2 ,3 ]
Vaziri, Farzam [2 ,3 ]
机构
[1] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[2] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Tehran 1316943551, Iran
[3] Pasteur Inst Iran, MRC, Tehran, Iran
关键词
Rifampin monoresistance; Mycobacterium tuberculosis; THP-1; Cytokines; Chemokines; GENE-EXPRESSION; UP-REGULATION; RESISTANCE; CELLS; ACTIVATION; INFECTION; SECRETION; AUTOPHAGY; PATHWAY; INNATE;
D O I
10.1016/j.cyto.2018.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages are the primary phagocytes in the lungs and a part of the host defense system against Mycobacterium tuberculosis (Mtb), involved in the primary immune response. While several studies have assessed the effects of resistance to rifampin on Mtb physiology, the consequences of mutations in genes encoding the beta subunit of RNA polymerase (rpoB) for host-pathogen interactions remain poorly understood. In this study, rifampin-monoresistant (RMR) Mtb and H37Rv strains were used to infect the THP-1-derived macrophages. Realtime quantitative reverse transcription PCR assay was carried out to determine mRNA expression in 84 cytokine and chemokine genes. Production of specific cytokines and chemokines was measured by ELISA assay. In conclusion, the current study shed more light on the fitness cost of RMR strain and the potential effects of rpoB gene mutations on Mtb-host interactions. These results initially demonstrate that the Mtb carrying the rpoB-S450L can modulate macrophage responses to mediate bacterial survival.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 53 条
[1]   IL-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated THP-1 Human Macrophages [J].
Bai, Xiyuan ;
Kim, Soo-Hyun ;
Azam, Tania ;
McGibney, Mischa T. ;
Huang, Hua ;
Dinarello, Charles A. ;
Chan, Edward D. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (07) :3830-3840
[2]   Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant, rpoB Mutant Mycobacterium tuberculosis [J].
Bisson, Gregory P. ;
Mehaffy, Carolina ;
Broeckling, Corey ;
Prenni, Jessica ;
Rifat, Dalin ;
Lun, Desmond S. ;
Burgos, Marcos ;
Weissman, Drew ;
Karakousis, Petros C. ;
Dobos, Karen .
JOURNAL OF BACTERIOLOGY, 2012, 194 (23) :6441-6452
[3]   Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis [J].
Cambier, C. J. ;
Falkow, Stanley ;
Ramakrishnan, Lalita .
CELL, 2014, 159 (07) :1497-1509
[4]   Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids [J].
Cambier, C. J. ;
Takaki, Kevin K. ;
Larson, Ryan P. ;
Hernandez, Rafael E. ;
Tobin, David M. ;
Urdahl, Kevin B. ;
Cosma, Christine L. ;
Ramakrishnan, Lalita .
NATURE, 2014, 505 (7482) :218-+
[5]   Abnormal production of transforming growth factor β and interferon γ by peripheral blood cells of patients with multidrug-resistant pulmonary tuberculosis in Brazil [J].
Castro, AZ ;
Diaz-Bardalez, BM ;
Oliveira, EC ;
Garcia, RC ;
Afiune, JB ;
Paschoal, IA ;
Santos, LMB .
JOURNAL OF INFECTION, 2005, 51 (04) :318-324
[6]   Drug Resistant Clinical Isolates of Mycobacterium tuberculosis from Different Genotypes Exhibit Differential Host Responses in THP-1 Cells [J].
Chakraborty, Pampi ;
Kulkarni, Savita ;
Rajan, Ramakrishna ;
Sainis, Krishna .
PLOS ONE, 2013, 8 (05)
[7]   THP-1 cell line: An in vitro cell model for immune modulation approach [J].
Chanput, Wasaporn ;
Mes, Jurriaan J. ;
Wichers, Harry J. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 23 (01) :37-45
[8]  
Chatterjee S., 2015, Current Tropical Medicine Reports, V2, P49, DOI DOI 10.1007/S40475-015-0047-X
[9]   More than merely drug resistance [J].
Chen, Yu-Xiang ;
Javid, Babak .
NATURE MICROBIOLOGY, 2018, 3 (10) :1078-1079
[10]   Role of innate cytokines in mycobacterial infection [J].
Cooper, A. M. ;
Mayer-Barber, K. D. ;
Sher, A. .
MUCOSAL IMMUNOLOGY, 2011, 4 (03) :252-260